OTC Markets OTCPK - Delayed Quote ? USD CanadaBis Capital Inc. (CNADF) Follow Compare 0.0500 +0.0500 (0.00%) At close: October 11 at 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations CanadaBis Capital Third Quarter 2024 Earnings: EPS: CA$0.072 (vs CA$0.009 in 3Q 2023) CanadaBis Capital ( CVE:CANB ) Third Quarter 2024 Results Key Financial Results Revenue: CA$3.97m (down 34% from 3Q... Simply Wall St. ? 3 months ago CNADF 0.00% CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024 CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are filed on SEDAR at www.sedarplus.ca. This quarter reflects another period generating positive earnings and Adjusted EBITDA1 for Ca CNW Group ? 3 months ago CNADF 0.00% CanadaBis Capital Inc.'s (CVE:CANB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? It is hard to get excited after looking at CanadaBis Capital's (CVE:CANB) recent performance, when its stock has... Simply Wall St. ? 3 months ago CNADF 0.00% Canadabis Capital Expands into European Market with EU-GMP Partners Canadabis Capital (TSXV: CANB) with Sub Stigma Grow, a leading Canadian cannabis company, is pleased to announce its strategic expansion into the European market through a significant distribution agreement. This marks a pivotal moment in Stigma Grows history, as the company's innovative products will now be introduced to international markets. CNW Group ? 5 months ago CNADF 0.00% Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience. CNW Group ? 5 months ago CNADF 0.00% CANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES FISCAL Q2 2024 RESULTS HIGHLIGHTED BY CONTINUED POSITIVE ADJUSTED EBITDA(1) AND NET INCOME CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are filed on SEDAR at www.sedarplus.ca. CNW Group ? 6 months ago CNADF 0.00% CANADABIS CAPITAL CONFIRMS NO MATERIAL CHANGE At the request of CIRO, CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. CNW Group ? 6 months ago CNADF 0.00% CANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES FISCAL Q1 2024 RESULTS HIGHLIGHTED BY YEAR-OVER-YEAR GROWTH IN REVENUE, ADJUSTED EBITDA1 AND NET INCOME CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce our first quarter fiscal 2024 results featuring another consecutive period of growth in gross and net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are available on our website and filed on SEDAR at www.sedar.com. CNW Group ? 9 months ago CNADF 0.00% CANADABIS CAPITAL, WITH SUB STIGMA GROW, CONFIRMS ANOTHER RECORD FISCAL YEAR OF RESULTS IN 2023, HIGHLIGHTED BY SIGNIFICANT GROWTH IN NET REVENUE, GROSS PROFIT AND EARNINGS CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce another consecutive year of record results for the fiscal year ended July 31, 2023, and the eighth straight quarter generating positive net income. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are available on CanadaBis' website and filed on SEDAR at www.sedar.com. CNW Group ? 10 months ago CNADF 0.00% CANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES INDUSTRY-LEADING ACHIEVEMENT AFTER WINNING PRODUCT OF THE YEAR AWARD AND PROVIDES CORPORATE UPDATE CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is proud to announce a landmark achievement with subsidiary Stigma Grow being the recipient of Grow Up Industry's coveted 2023 Product of the Year award for Dab Bods' Phoenix Tears ("Phoenix Tears"). We extend heartfelt congratulations to our dedicated employees at Stigma Grow, whose continued hard work and ongoing commitment to excellence have culminated in this award. CNW Group ? 11 months ago CNADF 0.00% Performance Overview Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return CNADF S&P/TSX Composite index YTD -77.27% +18.44% 1-Year -73.68% +26.05% 3-Year -80.00% +25.29%
